Moxonidin Actavis (Moxonidine)

Moxonidine, the active ingredient in Moxonidin Actavis, is an imidazoline receptor agonist presented as an oral tablet for oral use. It treats hypertension by reducing sympathetic nervous system activity in adult patients.

GNH USA supplies Moxonidin Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine is a centrally acting antihypertensive that lowers blood pressure through modulation of sympathetic outflow. - Essential hypertension: reduces systolic and diastolic blood pressure in adults. - Resistant hypertension: provides additional blood‑pressure control when other agents are insufficient. - Isolated systolic hypertension: helps lower elevated systolic pressure, particularly in older patients.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially on standing. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Hepatic enzyme elevation: abnormal liver function tests. - Syncope: sudden loss of consciousness. - Electrolyte disturbances: abnormal potassium or sodium levels.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Monitor blood pressure: check regularly to ensure therapeutic response. - Assess renal function: adjust dosing in patients with impaired kidneys. - Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension. - Caution in elderly: increased sensitivity to hypotensive effects. - Store at room temperature: keep in the original pack, protect from moisture.

Moxonidine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other antihypertensives: risk of excessive hypotension. - MAO inhibitors: may potentiate blood‑pressure lowering. - Potassium‑sparing diuretics: monitor electrolytes closely.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: additive reduction in blood pressure. - NSAIDs: may diminish antihypertensive efficacy. - Alcohol: can enhance dizziness and hypotensive effects.